|
Deficiency Letter, IDE Review Changes May Be Among MDUFA Gifts to Industry
Higher user fees and the FDA’s corresponding pledge to improve performance at CDRH stole the spotlight during the Medical Device User Fee Act (MDUFA) reauthorization process earlier this year.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives